Literature DB >> 29482869

Determination of Intrafraction Prostate Motion During External Beam Radiation Therapy With a Transperineal 4-Dimensional Ultrasound Real-Time Tracking System.

Dwi Seno Kuncoro Sihono1, Michael Ehmann2, Sigrun Heitmann2, Sandra von Swietochowski2, Mario Grimm2, Judit Boda-Heggemann2, Frank Lohr3, Frederik Wenz2, Hansjörg Wertz2.   

Abstract

PURPOSE/
OBJECTIVE: To determine intrafraction prostate motion during volumetric modulated arc therapy (VMAT) using transperineal ultrasound (US) real-time tracking. METHODS AND MATERIALS: 770 US monitoring sessions in 38 prostate cancer patients' VMAT treatment series were retrospectively evaluated. Intrafraction motion assessment of the prostate was based on continuous position monitoring with a 4-dimensional US system along the 3 directions: left-right (LR), anterior-posterior (AP), and inferior-superior (SI). The overall mean values and standard deviations (SD) along with random and systematic errors were calculated.
RESULTS: The mean duration of each monitoring session was 254 s. The mean (μ), the systematic error (Σ), and the random error (σ) of intrafraction prostate displacement were μ = (0.01, -0.08, 0.15) mm, Σ = (0.30, 0.34, 0.23) mm, and σ = (0.59, 0.73, 0.64) mm in the LR, AP and SI directions, respectively. The percentage of treatments for which prostate displacement was ≤2 mm was 97.01%, 92.24%, and 95.77% in the LR, AP, and SI directions, respectively. At 60 s, a vector length of prostate displacement >2 mm was present in 0.67% of the data. The percentage increased to 2.42%, 6.14%, and 9.35% at 120 s, 180 s, and 240 s, respectively.
CONCLUSIONS: The magnitudes of intrafraction prostate motion along the SI and AP directions were comparable. On average, the smallest motion was in the LR direction and the largest in AP direction. Most of the prostate displacements were within a few millimeters. However, with increasing treatment time (eg, during hypofractionation), larger 3-dimensional prostate displacements up to 18.30 mm could be observed. Shortening treatment time can reduce the impact of intrafraction motion and potentially allows smaller safety margins.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29482869     DOI: 10.1016/j.ijrobp.2018.01.040

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  On-line daily plan optimization combined with a virtual couch shift procedure to address intrafraction motion in prostate magnetic resonance guided radiotherapy.

Authors:  Daan M de Muinck Keizer; Jochem R N van der Voort van Zyp; Eline N de Groot-van Breugel; Bas W Raaymakers; Jan J W Lagendijk; Hans C J de Boer
Journal:  Phys Imaging Radiat Oncol       Date:  2021-07-25

2.  Injection of hydrogel spacer increased maximal intrafractional prostate motion in anterior and superior directions during volumetric modulated arc therapy-stereotactic body radiation therapy for prostate cancer.

Authors:  Subaru Sawayanagi; Hideomi Yamashita; Mami Ogita; Ryosuke Takenaka; Yuki Nozawa; Yuichi Watanabe; Toshikazu Imae; Osamu Abe
Journal:  Radiat Oncol       Date:  2022-02-23       Impact factor: 3.481

3.  Evaluation of internal margins for prostate for step and shoot intensity-modulated radiation therapy and volumetric modulated arc therapy using different margin formulas.

Authors:  Daiki Higuchi; Tomohiro Ono; Ryo Kakino; Rihito Aizawa; Naoki Nakayasu; Hitoshi Ito; Takashi Sakamoto
Journal:  J Appl Clin Med Phys       Date:  2022-06-19       Impact factor: 2.243

4.  Prostate deformation during hypofractionated radiotherapy: an analysis of implanted fiducial marker displacement.

Authors:  Lukas Knybel; Jakub Cvek; Tomas Blazek; Andrea Binarova; Tereza Parackova; Kamila Resova
Journal:  Radiat Oncol       Date:  2021-12-07       Impact factor: 3.481

5.  Factors affecting accuracy and precision in ultrasound guided radiotherapy.

Authors:  Alexander Grimwood; Karen Thomas; Sally Kember; Georgina Aldis; Rebekah Lawes; Beverley Brigden; Jane Francis; Emer Henegan; Melanie Kerner; Louise Delacroix; Alexandra Gordon; Alison Tree; Emma J Harris; Helen A McNair
Journal:  Phys Imaging Radiat Oncol       Date:  2021-05-29

6.  Dosimetric benefits of daily treatment plan adaptation for prostate cancer stereotactic body radiotherapy.

Authors:  Miriam Eckl; Gustavo R Sarria; Sandra Springer; Marvin Willam; Arne M Ruder; Volker Steil; Michael Ehmann; Frederik Wenz; Jens Fleckenstein
Journal:  Radiat Oncol       Date:  2021-08-04       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.